Diagnostics & Research
Diagnostic tests improve patient care, contribute to the protection of consumer health, and help to limit healthcare spending. The founder of Life Science Partner, Tom Callaway, helped the original launch of PCR diagnostics and helped commercialize the first DNA sequencing tests for clinical use. With the emergence of personalized medicine to help select appropriate drugs for specific patients, diagnostic companies are seeking leaders who understand the full spectrum of healthcare – from sequencing, information technologies, patient care, and pharmaceutical drug development. Life Science Partner excels in recruiting top scientific and business leaders in large and small companies within this emerging field.
Featured Press Release
Robert Superko, MD
Vice President of Medical Affairs
Co-Founder of Berkeley HeartLab
Life Science Partner announces the recruitment of Robert Superko, MD, most recently Executive Director of Genomics and Human Health at St. Joseph’s Hospital of Atlanta’s Translational Research Institute, to Celera. Celera is a healthcare business delivering personalized disease management through a combination of products and services incorporating proprietary discoveries, including a clinical services business, Berkeley HeartLab (BHL). Celera commercializes a wide range of molecular diagnostic products and technologies to provide personalized disease management in cancer and liver diseases.
Dr. Superko is a world leader in the field of metabolic heart disease diagnosis and treatment, and genomics, which is the ability to tailor treatment specifically to a patient based on their genetic makeup. He has published over 100 manuscripts and 19 textbook chapters and is the author of BEFORE THE HEART ATTACKS, a book written for the lay public explaining advanced aspects of heart disease.
In his role at St. Joseph’s Hospital, Dr. Superko continued his research to identify patients’ genetic susceptibility to heart disease, cancer and other chronic disease states. A co-founder of BHL, Dr. Superko will serve as Vice President of Medical Affairs where he will be the key medical spokesperson for the company’s products and services and the key liaison with physician and research collaborators, including academic medical centers, pharmaceutical companies, and the FDA.
Dr. Superko earned his Bachelor of Science degree in Biology from University of California, San Diego, and his Medical degree from the State University of New York, Stony Brook.